LAMIVUDINE-HBV - ORAL

LAMIVUDINE-HBV - ORAL

PHONETIC PRONUNCIATION: (la-MIV-ue-deen)

COMMON BRAND NAME(S): Epivir HBV

GENERIC NAME(S): lamivudine

Uses

USES: Lamivudine-HBV is used to treat hepatitis B infection. It is not a cure for hepatitis B and does not prevent the passing of hepatitis B to others. This medication is a nucleoside reverse transcriptase inhibitor (NRTI) that works by slowing the growth of the virus, thereby decreasing liver damage caused by the virus.


How to use LAMIVUDINE-HBV - ORAL

HOW TO USE: Read the Patient Information Leaflet provided by your pharmacist before you start using lamivudine-HBV and each time you get a refill. If you have any questions regarding the information, consult your doctor or pharmacist. Take lamivudine-HBV by mouth with or without food, usually once a day or as directed by your doctor. Use this medicine regularly in order to get the most benefit from it. This medication works best when the amount of drug in your body is kept at a constant level. Remember to use it at the same time each day. Do not skip any doses. Dosage is based on your medical condition and response to therapy. Do not stop taking this medication without consulting your doctor. Worsening of your condition, decreased response to medication, or development of drug-resistant types of the virus may occur during or after treatment. Promptly report any new symptoms that occur during or after treatment to your doctor.

Side Effects

SIDE EFFECTS: Nausea, vomiting, diarrhea, dizziness, headache, fatigue, or infections of the ear/nose/throat may occur. If any of these effects persist or worsen, notify your doctor or pharmacist promptly. Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. Tell your doctor right away if any of these unlikely but serious side effects occur: mental/mood changes, muscle/joint pain, persistent nausea/vomiting, stomach/abdominal pain, dark urine, yellowing of eyes/skin. Tell your doctor right away if any of these rare but very serious side effects occur: deep/rapid breathing, drowsiness, tingling/numbness in hands or feet. A very serious allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction may include: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

Precautions

PRECAUTIONS: Before taking lamivudine-HBV, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. This medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have: pancreatitis. Before using lamivudine-HBV, tell your doctor or pharmacist your medical history, especially of: HIV infection, kidney disease, blood disorders, liver disease. This drug may make you dizzy or drowsy. Alcohol or marijuana can make you more dizzy or drowsy. Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Avoid alcoholic beverages. Talk to your doctor if you are using marijuana. Liquid preparations of lamivudine-HBV contain sugar (sucrose). If you are a diabetic using the liquid form of this drug, closer monitoring of your blood sugar is recommended as you begin using this drug. Talk with your doctor or pharmacist for more details. Kidney function declines as you grow older. This medication is removed by the kidneys. Therefore, elderly people may be at a greater risk for side effects while using this drug. Children, especially those with pancreatitis, may be more sensitive to the effects of this drug. This medication should be used only when clearly needed during pregnancy. Discuss the risks and benefits with your doctor. This medication has not been shown to prevent the passing of hepatitis B from the mother to the newborn. Consult your doctor for more information. This medication may pass into breast milk and have undesirable effects on a nursing infant. Therefore, breast-feeding is not recommended while using this drug. Consult your doctor before breast-feeding.

Interactions

DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval. A product that may interact with this drug is: sorbitol. Do not take this medication with other products (including those that treat HIV infection) that contain lamivudine. Emtricitabine is similar to lamivudine and should not be taken with this medication. Lamivudine-HBV can affect the results of certain lab tests (e.g., liver function tests). Make sure laboratory personnel and your doctors know you use this drug.

Overdose

OVERDOSE: If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.

Images

EPIVIR HBV 100 MG TABLET

color
butterscotch
shape
oblong
imprint
GX CG5

color
peach
shape
oblong
imprint
M, LN4
LAMIVUDINE HBV 100 MG TABLET

color
pink
shape
oblong
imprint
37, I
LAMIVUDINE HBV 100 MG TABLET

color
orange-brown
shape
oblong
imprint
APO, LMV 100
LAMIVUDINE HBV 100 MG TABLET

color
butterscotch
shape
oblong
imprint
GX CG5

Reviews

No Reviews Yet


Faq for LAMIVUDINE-HBV - ORAL

Lamivudine-HBV is an oral medication used to treat chronic hepatitis B virus (HBV) infection.

Lamivudine-HBV works by inhibiting the replication of the HBV virus, reducing its levels in the body and improving liver function.

Lamivudine-HBV is taken orally as directed by a healthcare professional, usually once daily. It can be taken with or without food.

The common side effects of lamivudine-HBV include headache, diarrhea, fatigue, dizziness, and nausea. Serious side effects such as lactic acidosis and liver dysfunction are rare but possible.

Lamivudine-HBV can suppress the HBV virus and improve liver function in many patients, but it may not completely eradicate the virus. It is important to continue taking the medication as prescribed to maintain the viral suppression.

Pregnant or breastfeeding women should consult with their healthcare provider before taking lamivudine-HBV, as its safety during pregnancy and breastfeeding is not well established.

If you miss a dose of lamivudine-HBV, take it as soon as you remember. However, if it is near the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.

Lamivudine-HBV may interact with certain medications, including those with a similar mechanism of action or those that affect kidney function. It is important to inform your healthcare provider about all the medications you are taking.

The duration of lamivudine-HBV treatment can vary depending on individual patient factors and the severity of the HBV infection. It is important to follow your healthcare provider's instructions regarding the duration of treatment.


Warning

WARNING: Lactic acid buildup in the blood (lactic acidosis) and sometimes fatal liver disease have occurred with the use of lamivudine-HBV, used both alone and in combination with other drugs for treating human immunodeficiency virus (HIV) infection. HIV counseling and testing should be offered to all patients both before and during treatment with lamivudine-HBV. Lamivudine-HBV contains a lower dose of the drug lamivudine, which is used to treat HIV infection as well as hepatitis B. Use of lamivudine-HBV in patients with unknown or untreated HIV infection could result in new types of HIV virus that are more difficult to treat (drug-resistant). Severe worsening of hepatitis has occurred when this medication is stopped. Liver and blood testing should continue for several months after lamivudine-HBV is stopped. Consult your doctor or pharmacist for more information.


Disclaimer

IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.